• Health & Medicine
• Policy & Insight

Cancer survival in England still lagging behind other countries

A lack of improvement in early diagnosis rates means cancer survival in England continues to lag behind leading countries, a new report reveals. A lack of improvement in early diagnosis rates means cancer survival in England continues to lag behind leading countries, a new report reveals.

27 November 2018

• Health & Medicine
• Policy & Insight

London Mayor confirms junk food ad ban on transport network

Junk food advertising will be banned on public transport in London from February 2019, the Mayor of London Sadiq Khan confirmed today.  Junk food advertising will be banned on public transport in London from February 2019, the Mayor of London Sadiq Khan confirmed today. 

23 November 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with lung cancer

Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England. Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England.

22 November 2018

• Health & Medicine

Sugar supplement slows tumour growth and can improve cancer treatment in mice

Mannose sugar, a nutritional supplement, can both slow tumour growth and enhance the effects of chemotherapy in mice with multiple types of cancer. Mannose sugar, a nutritional supplement, can both slow tumour growth and enhance the effects of chemotherapy in mice with multiple types of cancer.

21 November 2018

• Health & Medicine

Immunotherapy drug to be made available for some NHS patients with advanced skin cancer

Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England. Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England.

21 November 2018

• Health & Medicine

Mirati Therapeutics joins Cancer Research UK’s Stratified Medicine Programme

Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme. Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme.

20 November 2018

• Health & Medicine

Standard chemo still most effective for throat cancers caused by HPV

Standard chemotherapy remains the most effective way to treat a particular form of throat cancer, according to new research. Standard chemotherapy remains the most effective way to treat a particular form of throat cancer, according to new research.

16 November 2018

• Charity News

Cancer Research UK's new chief executive takes up post

Michelle Mitchell OBE, Cancer Research UK’s new CEO, begins her leadership of the charity today, 12 November 2018. Michelle Mitchell OBE, Cancer Research UK’s new CEO, begins her leadership of the charity today, 12 November 2018.

12 November 2018

• Health & Medicine

Doctor and dad duo design new 'cancer maps' to aid diagnosis

A GP and his dad have invented a new online mind-mapping tool for doctors that aims to help GPs speed up cancer diagnosis A GP and his dad have invented a new online mind-mapping tool for doctors that aims to help GPs speed up cancer diagnosis

8 November 2018

• Science & Technology

Study shows potential to develop brain tumour liquid biopsies

Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine. Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine.

6 November 2018

• Health & Medicine

Computer simulation suggests testing for HPV first could mean cervical screening can be stopped earlier

Cervical screening could be stopped at the age of 55 for some women if the HPV test is used first, according to a new computer simulation study. Cervical screening could be stopped at the age of 55 for some women if the HPV test is used first, according to a new computer simulation study.

2 November 2018

• Health & Medicine

Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

24 October 2018